232 related articles for article (PubMed ID: 1701232)
1. The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas.
Santoro M; Rosati R; Grieco M; Berlingieri MT; D'Amato GL; de Franciscis V; Fusco A
Oncogene; 1990 Oct; 5(10):1595-8. PubMed ID: 1701232
[TBL] [Abstract][Full Text] [Related]
2. Expression of the ret proto-oncogene in human medullary thyroid carcinomas and pheochromocytomas of MEN 2A.
Miya A; Yamamoto M; Morimoto H; Tanaka N; Shin E; Karakawa K; Toyoshima K; Ishizaka Y; Mori T; Takai S
Henry Ford Hosp Med J; 1992; 40(3-4):215-9. PubMed ID: 1362408
[TBL] [Abstract][Full Text] [Related]
3. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
Komminoth P
Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
[TBL] [Abstract][Full Text] [Related]
4. Detection of retTPC/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method.
Ishizaka Y; Kobayashi S; Ushijima T; Hirohashi S; Sugimura T; Nagao M
Oncogene; 1991 Sep; 6(9):1667-72. PubMed ID: 1717926
[TBL] [Abstract][Full Text] [Related]
5. Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.
Santoro M; Carlomagno F; Hay ID; Herrmann MA; Grieco M; Melillo R; Pierotti MA; Bongarzone I; Della Porta G; Berger N
J Clin Invest; 1992 May; 89(5):1517-22. PubMed ID: 1569189
[TBL] [Abstract][Full Text] [Related]
6. Identification and analysis of the ret proto-oncogene promoter region in neuroblastoma cell lines and medullary thyroid carcinomas from MEN2A patients.
Itoh F; Ishizaka Y; Tahira T; Yamamoto M; Miya A; Imai K; Yachi A; Takai S; Sugimura T; Nagao M
Oncogene; 1992 Jun; 7(6):1201-6. PubMed ID: 1350670
[TBL] [Abstract][Full Text] [Related]
7. RET proto-oncogene mutations and rearrangements in endocrine diseases.
Lloyd RV
Am J Pathol; 1995 Dec; 147(6):1539-44. PubMed ID: 7495277
[No Abstract] [Full Text] [Related]
8. The RET proto-oncogene in sporadic pheochromocytomas.
Takaya K; Yoshimasa T; Arai H; Tamura N; Miyamoto Y; Itoh H; Nakao K
Intern Med; 1996 Jun; 35(6):449-52. PubMed ID: 8835594
[TBL] [Abstract][Full Text] [Related]
9. Mutation analysis of the c-mos proto-oncogene and the endothelin-B receptor gene in medullary thyroid carcinoma and phaeochromocytoma.
Eng C; Foster KA; Healey CS; Houghton C; Gayther SA; Mulligan LM; Ponder BA
Br J Cancer; 1996 Aug; 74(3):339-41. PubMed ID: 8695346
[TBL] [Abstract][Full Text] [Related]
10. Detection of RET oncogene activation in human papillary thyroid carcinomas by in situ hybridisation.
Fabien N; Paulin C; Santoro M; Berger N; Grieco M; Galvain D; Barbier Y; Dubois PM; Fusco A
Br J Cancer; 1992 Dec; 66(6):1094-8. PubMed ID: 1457350
[TBL] [Abstract][Full Text] [Related]
11. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.
Grieco M; Santoro M; Berlingieri MT; Melillo RM; Donghi R; Bongarzone I; Pierotti MA; Della Porta G; Fusco A; Vecchio G
Cell; 1990 Feb; 60(4):557-63. PubMed ID: 2406025
[TBL] [Abstract][Full Text] [Related]
12. Low frequency of rearrangements of the ret and trk proto-oncogenes in Japanese thyroid papillary carcinomas.
Wajjwalku W; Nakamura S; Hasegawa Y; Miyazaki K; Satoh Y; Funahashi H; Matsuyama M; Takahashi M
Jpn J Cancer Res; 1992 Jul; 83(7):671-5. PubMed ID: 1381340
[TBL] [Abstract][Full Text] [Related]
13. Low rate of ret proto-oncogene activation (PTC/retTPC) in papillary thyroid carcinomas from Saudi Arabia.
Zou M; Shi Y; Farid NR
Cancer; 1994 Jan; 73(1):176-80. PubMed ID: 8275421
[TBL] [Abstract][Full Text] [Related]
14. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.
Eng C; Smith DP; Mulligan LM; Nagai MA; Healey CS; Ponder MA; Gardner E; Scheumann GF; Jackson CE; Tunnacliffe A
Hum Mol Genet; 1994 Feb; 3(2):237-41. PubMed ID: 7911697
[TBL] [Abstract][Full Text] [Related]
15. Expression of the RET proto-oncogene in normal human tissues, pheochromocytomas, and other tumors of neural crest origin.
Takaya K; Yoshimasa T; Arai H; Tamura N; Miyamoto Y; Itoh H; Nakao K
J Mol Med (Berl); 1996 Oct; 74(10):617-21. PubMed ID: 8912182
[TBL] [Abstract][Full Text] [Related]
16. RET proto-oncogene point mutations in sporadic neuroendocrine tumors.
Komminoth P; Roth J; Muletta-Feurer S; Saremaslani P; Seelentag WK; Heitz PU
J Clin Endocrinol Metab; 1996 Jun; 81(6):2041-6. PubMed ID: 8964826
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.
Santoro M; Dathan NA; Berlingieri MT; Bongarzone I; Paulin C; Grieco M; Pierotti MA; Vecchio G; Fusco A
Oncogene; 1994 Feb; 9(2):509-16. PubMed ID: 8290261
[TBL] [Abstract][Full Text] [Related]
18. Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas.
Lanzi C; Borrello MG; Bongarzone I; Migliazza A; Fusco A; Grieco M; Santoro M; Gambetta RA; Zunino F; Della Porta G
Oncogene; 1992 Nov; 7(11):2189-94. PubMed ID: 1437145
[TBL] [Abstract][Full Text] [Related]
19. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.
Mulligan LM; Kwok JB; Healey CS; Elsdon MJ; Eng C; Gardner E; Love DR; Mole SE; Moore JK; Papi L
Nature; 1993 Jun; 363(6428):458-60. PubMed ID: 8099202
[TBL] [Abstract][Full Text] [Related]
20. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas.
Jhiang SM; Sagartz JE; Tong Q; Parker-Thornburg J; Capen CC; Cho JY; Xing S; Ledent C
Endocrinology; 1996 Jan; 137(1):375-8. PubMed ID: 8536638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
